$CHE
CHEMED CORP

2020 Q3 Form 10-Q Financial Statement

#000001958420000042 Filed on November 04, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3 2019 Q2
Revenue $528.3M $480.6M $473.6M
YoY Change 9.92% 8.21% 7.19%
Cost Of Revenue $339.2M $328.2M $323.6M
YoY Change 3.37% 7.49% 5.85%
Gross Profit $189.1M $152.4M $149.9M
YoY Change 24.03% 9.79% 10.2%
Gross Profit Margin 35.79% 31.72% 31.66%
Selling, General & Admin $88.32M $76.84M $71.56M
YoY Change 14.94% 14.38% 4.77%
% of Gross Profit 46.71% 50.41% 47.72%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $11.71M $10.15M $9.887M
YoY Change 15.44% 5.07% 1.74%
% of Gross Profit 6.2% 6.66% 6.59%
Operating Expenses $88.32M $76.84M $71.56M
YoY Change 14.94% 14.38% 4.77%
Operating Profit $74.31M $64.93M $65.53M
YoY Change 14.45% 5.21% 12.71%
Interest Expense $379.0K $1.041M $1.237M
YoY Change -63.59% -3.79% -18.83%
% of Operating Profit 0.51% 1.6% 1.89%
Other Income/Expense, Net $7.675M $3.036M $13.00K
YoY Change 152.8% 32.0% -98.75%
Pretax Income $81.60M $66.92M $64.30M
YoY Change 21.94% 6.34% 11.53%
Income Tax $13.88M $7.976M $13.58M
% Of Pretax Income 17.01% 11.92% 21.11%
Net Earnings $67.72M $58.95M $50.73M
YoY Change 14.89% 15.02% -7.72%
Net Earnings / Revenue 12.82% 12.26% 10.71%
Basic Earnings Per Share $4.25 $3.69 $3.18
Diluted Earnings Per Share $4.14 $3.56 $3.08
COMMON SHARES
Basic Shares Outstanding 15.94M 15.97M 15.93M
Diluted Shares Outstanding 16.37M 16.56M 16.45M

Balance Sheet

Concept 2020 Q3 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $112.8M $9.100M $3.300M
YoY Change 1139.56% -86.52% -74.02%
Cash & Equivalents $112.8M $9.066M $3.323M
Short-Term Investments
Other Short-Term Assets $39.40M $36.90M $34.40M
YoY Change 6.78% 56.36% -4.18%
Inventory $7.546M $7.354M $6.336M
Prepaid Expenses
Receivables $110.8M $114.5M $136.1M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $270.6M $167.8M $180.2M
YoY Change 61.27% -18.49% 3.91%
LONG-TERM ASSETS
Property, Plant & Equipment $181.4M $172.9M $149.9M
YoY Change 4.89% 11.98% 2.75%
Goodwill $578.5M $576.6M $510.6M
YoY Change 0.33% 19.31%
Intangibles $120.4M $129.3M $67.51M
YoY Change -6.87% 128.21%
Long-Term Investments $86.90M $73.70M $70.50M
YoY Change 17.91% 4.99% 4.29%
Other Assets $8.805M $8.982M $8.874M
YoY Change -1.97% 3.8% 13.77%
Total Long-Term Assets $1.096B $1.065B $913.9M
YoY Change 2.96% 37.7% 21.08%
TOTAL ASSETS
Total Short-Term Assets $270.6M $167.8M $180.2M
Total Long-Term Assets $1.096B $1.065B $913.9M
Total Assets $1.367B $1.233B $1.094B
YoY Change 10.9% 25.89% 17.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $39.27M $44.03M $51.14M
YoY Change -10.81% 19.07% 52.21%
Accrued Expenses $195.5M $164.0M $137.1M
YoY Change 19.21% 41.87% 47.42%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $6.200M $15.50M
YoY Change -100.0% 6.16%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $329.2M $251.5M $223.7M
YoY Change 30.88% 39.57% 34.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $130.0M $85.00M
YoY Change -100.0% 0.0% -17.79%
Other Long-Term Liabilities $31.05M $7.845M $7.754M
YoY Change 295.73% -53.82% -90.68%
Total Long-Term Liabilities $31.05M $137.8M $92.75M
YoY Change -77.48% -6.22% -50.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $329.2M $251.5M $223.7M
Total Long-Term Liabilities $31.05M $137.8M $92.75M
Total Liabilities $565.5M $560.2M $475.5M
YoY Change 0.95% 36.31% 27.89%
SHAREHOLDERS EQUITY
Retained Earnings $1.615B $1.365B $1.311B
YoY Change 18.32% 16.1%
Common Stock $961.4M $877.6M $852.8M
YoY Change 9.55% 11.02%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.778B $1.573B $1.548B
YoY Change 13.03% 12.3%
Treasury Stock Shares $20.26M $19.81M $19.75M
Shareholders Equity $801.4M $672.4M $618.6M
YoY Change
Total Liabilities & Shareholders Equity $1.367B $1.233B $1.094B
YoY Change 10.9% 25.89% 17.87%

Cashflow Statement

Concept 2020 Q3 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income $67.72M $58.95M $50.73M
YoY Change 14.89% 15.02% -7.72%
Depreciation, Depletion And Amortization $11.71M $10.15M $9.887M
YoY Change 15.44% 5.07% 1.74%
Cash From Operating Activities $124.6M $128.7M $35.30M
YoY Change -3.19% 17.43% -36.74%
INVESTING ACTIVITIES
Capital Expenditures -$10.40M -$11.50M -$14.40M
YoY Change -9.57% -9.45% 27.43%
Acquisitions
YoY Change
Other Investing Activities $200.0K -$137.8M $0.00
YoY Change -100.15% 1141.44%
Cash From Investing Activities -$10.20M -$149.3M -$14.50M
YoY Change -93.17% 529.96% 28.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -22.00M 26.30M -26.30M
YoY Change -183.65% -184.84% -42.32%
NET CHANGE
Cash From Operating Activities 124.6M 128.7M 35.30M
Cash From Investing Activities -10.20M -149.3M -14.50M
Cash From Financing Activities -22.00M 26.30M -26.30M
Net Change In Cash 92.40M 5.700M -5.500M
YoY Change 1521.05% -89.62% 400.0%
FREE CASH FLOW
Cash From Operating Activities $124.6M $128.7M $35.30M
Capital Expenditures -$10.40M -$11.50M -$14.40M
Free Cash Flow $135.0M $140.2M $49.70M
YoY Change -3.71% 14.64% -25.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
31-0791746
dei Entity Address Address Line1
EntityAddressAddressLine1
255 E. Fifth Street
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15951822
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112765000
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2600
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-8351
dei Entity Registrant Name
EntityRegistrantName
CHEMED CORPORATION
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Entity Central Index Key
EntityCentralIndexKey
0000019584
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Address City Or Town
EntityAddressCityOrTown
Cincinnati
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
45202
dei City Area Code
CityAreaCode
513
dei Local Phone Number
LocalPhoneNumber
762-6690
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Capital Stock $1 Par Value
dei Trading Symbol
TradingSymbol
CHE
dei Security Exchange Name
SecurityExchangeName
NYSE
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6158000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1293000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
353000
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
110839000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
143827000
CY2020Q3 us-gaap Inventory Net
InventoryNet
7546000
CY2019Q4 us-gaap Inventory Net
InventoryNet
7462000
CY2020Q3 us-gaap Prepaid Taxes
PrepaidTaxes
14224000
CY2019Q4 us-gaap Prepaid Taxes
PrepaidTaxes
10074000
CY2020Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
25222000
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
23150000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
270596000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
190671000
CY2020Q3 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
86865000
CY2019Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
77446000
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
288657000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
270140000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
181386000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
175763000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
120382000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
111652000
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
45095000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
37620000
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
120401000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
126370000
CY2020Q3 us-gaap Goodwill
Goodwill
578519000
CY2019Q4 us-gaap Goodwill
Goodwill
577367000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8805000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9048000
CY2020Q3 us-gaap Assets
Assets
1366954000
CY2019Q4 us-gaap Assets
Assets
1268317000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
39268000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
51101000
CY2020Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
50727000
CY2019Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
50328000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
101868000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
70814000
CY2020Q3 us-gaap Litigation Reserve Current
LitigationReserveCurrent
9561000
CY2019Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
6941000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
33311000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39280000
CY2020Q3 che Unutilized Cares Act Grant
UnutilizedCaresActGrant
48041000
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
46387000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
43756000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
329163000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
262220000
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
19222000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
18504000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
90000000
CY2020Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
86875000
CY2019Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
76446000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
99241000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
86656000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
31045000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7883000
CY2020Q3 us-gaap Liabilities
Liabilities
565546000
CY2019Q4 us-gaap Liabilities
Liabilities
541709000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36137463
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35810528
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
36137000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
35811000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
925271000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
860671000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1615465000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1425752000
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
20261187
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
19867220
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
1777809000
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1597940000
CY2020Q3 che Deferred Compensation Payable In Company Stock
DeferredCompensationPayableInCompanyStock
2344000
CY2019Q4 che Deferred Compensation Payable In Company Stock
DeferredCompensationPayableInCompanyStock
2314000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
801408000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
726608000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1366954000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1268317000
CY2020Q3 us-gaap Revenues
Revenues
528297000
CY2019Q3 us-gaap Revenues
Revenues
480613000
us-gaap Revenues
Revenues
1546294000
us-gaap Revenues
Revenues
1416231000
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
339240000
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
328183000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1043148000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
973771000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
88317000
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
76836000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
243413000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
222421000
CY2020Q3 us-gaap Depreciation
Depreciation
11714000
CY2019Q3 us-gaap Depreciation
Depreciation
10147000
us-gaap Depreciation
Depreciation
34761000
us-gaap Depreciation
Depreciation
29744000
CY2020Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2511000
CY2019Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
441000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
7476000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1366000
CY2020Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-12207000
CY2019Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-78000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
28935000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-9001000
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
453989000
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
415685000
us-gaap Costs And Expenses
CostsAndExpenses
1299863000
us-gaap Costs And Expenses
CostsAndExpenses
1236303000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
74308000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
64928000
us-gaap Operating Income Loss
OperatingIncomeLoss
246431000
us-gaap Operating Income Loss
OperatingIncomeLoss
179928000
CY2020Q3 us-gaap Interest Expense
InterestExpense
379000
CY2019Q3 us-gaap Interest Expense
InterestExpense
1041000
us-gaap Interest Expense
InterestExpense
2005000
us-gaap Interest Expense
InterestExpense
3402000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7675000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3036000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5723000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5488000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
81604000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
66923000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
250149000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
182014000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13882000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7976000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
44435000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27671000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
67722000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
58947000
us-gaap Net Income Loss
NetIncomeLoss
205714000
us-gaap Net Income Loss
NetIncomeLoss
154343000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.25
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
12.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.68
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15940000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15970000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15948000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15952000
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.14
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
12.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
9.35
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16373000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16555000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16419000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16514000
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.34
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.32
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.98
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.92
us-gaap Net Income Loss
NetIncomeLoss
205714000
us-gaap Net Income Loss
NetIncomeLoss
154343000
che Ununtilized Cares Act Grant Operating Activity
UnuntilizedCaresActGrantOperatingActivity
48041000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
42237000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
31110000
che Deferred Payroll Taxes
DeferredPayrollTaxes
22941000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
13296000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
10729000
che Noncash Long Term Incentive Compensation
NoncashLongTermIncentiveCompensation
5301000
che Noncash Long Term Incentive Compensation
NoncashLongTermIncentiveCompensation
4184000
us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
2684000
us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
6000000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1171000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
767000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
831000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6085000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
229000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
229000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
2266000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-27993000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10558000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
84000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1649000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2072000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
6836000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
34526000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
28622000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-4366000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-81000
che Increase Decrease In Lease Assets And Liabilities
IncreaseDecreaseInLeaseAssetsAndLiabilities
-1583000
che Increase Decrease In Lease Assets And Liabilities
IncreaseDecreaseInLeaseAssetsAndLiabilities
-1311000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
9646000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
8145000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
10735000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
9045000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1298000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1277000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
402412000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
237645000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42670000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
39753000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3600000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
138010000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-672000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-101000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45598000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-177662000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
264900000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
359900000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
174900000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
400700000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
147123000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
71926000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
31498000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23383000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
18707000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
26108000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
15639000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
14657000
us-gaap Increase Decrease In Outstanding Checks Financing Activities
IncreaseDecreaseInOutstandingChecksFinancingActivities
-9849000
us-gaap Increase Decrease In Outstanding Checks Financing Activities
IncreaseDecreaseInOutstandingChecksFinancingActivities
-7535000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-387000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
295000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-250207000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-55748000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
106607000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4235000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6158000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4831000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112765000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9066000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
750696000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
67722000
CY2020Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.34
CY2020Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
5401000
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13152000
CY2020Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
24975000
CY2020Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
214000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
801408000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
618569000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
58947000
CY2019Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.32
CY2019Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
5090000
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
32000
CY2019Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
-78000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
672380000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
726608000
us-gaap Net Income Loss
NetIncomeLoss
205714000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.98
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
15639000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
32558000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
147123000
us-gaap Stockholders Equity Other
StockholdersEquityOther
-710000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
801408000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
591334000
us-gaap Net Income Loss
NetIncomeLoss
154343000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.92
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
14657000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12956000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
71926000
us-gaap Stockholders Equity Other
StockholdersEquityOther
330000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
672380000
CY2020Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
37900000
CY2020Q3 che Number Of Cloud Computing Arrangements
NumberOfCloudComputingArrangements
2
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.170
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.119
CY2020Q3 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
7200000
CY2019Q3 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
8800000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.178
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.152
us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
19900000
us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
18700000
CY2020Q3 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
979000
CY2019Q4 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
1800000
us-gaap Use Of Estimates
UseOfEstimates
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">ESTIMATES</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Disclosures of after-tax expenses and adjustments are based on estimates of the effective income tax rates for the applicable segments.</span></p>
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
67722000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
58947000
us-gaap Net Income Loss
NetIncomeLoss
205714000
us-gaap Net Income Loss
NetIncomeLoss
154343000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
67722000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15940000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.25
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
358000
CY2020Q3 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
75000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
67722000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16373000
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.14
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
58947000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15970000
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.69
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
500000
CY2019Q3 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
85000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
58947000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16555000
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.56
us-gaap Net Income Loss
NetIncomeLoss
205714000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15948000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
12.90
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
394000
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
77000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
205714000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16419000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
12.53
us-gaap Net Income Loss
NetIncomeLoss
154343000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15952000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
9.68
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
484000
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
78000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
154343000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16514000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
9.35
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
277000
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
246000
CY2020Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
37900000
CY2020Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-12207000
CY2019Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-78000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
28935000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-9001000
CY2020Q3 che Market Value Gains On Assets Held In Deferred Compensation Trust
MarketValueGainsOnAssetsHeldInDeferredCompensationTrust
7256000
CY2019Q3 che Market Value Gains On Assets Held In Deferred Compensation Trust
MarketValueGainsOnAssetsHeldInDeferredCompensationTrust
2886000
che Market Value Gains On Assets Held In Deferred Compensation Trust
MarketValueGainsOnAssetsHeldInDeferredCompensationTrust
5093000
che Market Value Gains On Assets Held In Deferred Compensation Trust
MarketValueGainsOnAssetsHeldInDeferredCompensationTrust
5094000
CY2020Q3 us-gaap Investment Income Net
InvestmentIncomeNet
423000
CY2019Q3 us-gaap Investment Income Net
InvestmentIncomeNet
173000
us-gaap Investment Income Net
InvestmentIncomeNet
647000
us-gaap Investment Income Net
InvestmentIncomeNet
387000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-23000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7675000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3036000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5723000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5488000
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
up to 5 years
us-gaap Lessee Operating Lease Option To Terminate
LesseeOperatingLeaseOptionToTerminate
within 1 year
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
120382000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
111652000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
33311000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39280000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
99241000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
86656000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
132552000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
125936000
us-gaap Operating Lease Cost
OperatingLeaseCost
35181000
us-gaap Sublease Income
SubleaseIncome
38000
us-gaap Sublease Income
SubleaseIncome
6000
us-gaap Lease Cost
LeaseCost
44969000
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y1M6D
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0298
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
15277000
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
12728000
CY2020Q3 us-gaap Sublease Income
SubleaseIncome
31000
CY2020Q3 us-gaap Lease Cost
LeaseCost
15246000
CY2019Q3 us-gaap Lease Cost
LeaseCost
12728000
us-gaap Operating Lease Cost
OperatingLeaseCost
45007000
us-gaap Lease Cost
LeaseCost
35175000
us-gaap Operating Lease Payments
OperatingLeasePayments
37393000
us-gaap Operating Lease Payments
OperatingLeasePayments
30237000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
44366000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
38890000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
11344000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
39588000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
29719000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
22767000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
16931000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
27738000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
148087000
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10977000
CY2020Q3 che Lessee Operating Lease Future Lease Obligations Not Yet Commenced
LesseeOperatingLeaseFutureLeaseObligationsNotYetCommenced
4558000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
132552000
che Operating Lease Payments Include To Extended Lease Terms
OperatingLeasePaymentsIncludeToExtendedLeaseTerms
2300000
che Operating Lease Payments Exclude Leases Signed Not Yet Commenced
OperatingLeasePaymentsExcludeLeasesSignedNotYetCommenced
4600000
CY2020Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
11506000
CY2019Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
6445000
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
18445000
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
17155000
CY2020Q3 che Cash Overdraft Payable Included In Accounts Payable
CashOverdraftPayableIncludedInAccountsPayable
0
CY2019Q4 che Cash Overdraft Payable Included In Accounts Payable
CashOverdraftPayableIncludedInAccountsPayable
9800000
CY2020Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
24975000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
147123000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
71926000
CY2020Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
50000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
325000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
219009
CY2020Q3 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
499.48
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
452.69
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
328.41
CY2020Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
250000000.0
CY2020Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
206900000
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">16.    Recent Accounting Standards</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In March 2020, the FASB issued Accounting Standards Update “ASU No. 2020-04 - Reference Rate Reform”. The update provides optional expedients and exceptions for applying GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another rate expected to be discontinued. The update is effective for all entities as of March 12, 2020 and will apply through December 31, 2022. The interest rate charged on borrowings from our existing revolver is based on LIBOR. The credit agreement includes provisions for modifying the interest rate in the instance that LIBOR is discontinued. As a result, no contract modifications will be required when LIBOR is discontinued.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In December 2019, the FASB issued Accounting Standards Update “ASU No. 2019-12 – Simplifying the Accounting for Income Taxes”. The ASU adds new guidance to simplify accounting for income taxes, changes the accounting for certain income tax transactions and makes minor improvements to the codifications. The ASU is effective for the Company on January 1, 2021. We are currently evaluating the impact of this standard on our consolidated financial statements.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.50in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p>
CY2020Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
528297000
CY2019Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
500289000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1546674000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1480432000
CY2020Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
67722000
CY2019Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
62194000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
205773000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
164679000
CY2020Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
4.25
CY2019Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
3.89
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
12.90
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
10.32
CY2020Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
4.14
CY2019Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
3.76
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
12.53
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
9.97
CY2019Q4 us-gaap Goodwill
Goodwill
577367000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1193000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-41000
CY2020Q3 us-gaap Goodwill
Goodwill
578519000

Files In Submission

Name View Source Status
0000019584-20-000042-index-headers.html Edgar Link pending
0000019584-20-000042-index.html Edgar Link pending
0000019584-20-000042.txt Edgar Link pending
0000019584-20-000042-xbrl.zip Edgar Link pending
che-20200930.xsd Edgar Link pending
che-20200930x10q.htm Edgar Link pending
che-20200930x10q_htm.xml Edgar Link completed
che-20200930xex31_1.htm Edgar Link pending
che-20200930xex31_2.htm Edgar Link pending
che-20200930xex31_3.htm Edgar Link pending
che-20200930xex32_1.htm Edgar Link pending
che-20200930xex32_2.htm Edgar Link pending
che-20200930xex32_3.htm Edgar Link pending
che-20200930_cal.xml Edgar Link unprocessable
che-20200930_def.xml Edgar Link unprocessable
che-20200930_lab.xml Edgar Link unprocessable
che-20200930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending